http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009098648-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f88ffd5b39324f7634998eeb8ae0d6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a52edae915c7d3db98e227ac6dd6aaa
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5256
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
filingDate 2007-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c343331333d2c3b858d83cde8fe3d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a857ffcb60f91b1e1bb40bd1c413951e
publicationDate 2009-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2009098648-A1
titleOfInvention High-titer retroviral packaging cells
abstract The present invention relates to non-replicative recombinant retrovirus packaging cells able to grow in suspension in a serum-free medium. In particular, the present invention relates to a human embryonic 293SF-based cell line stably expressing gag and pol gene products from the murine Moloney leukemia virus (MLV) and either the feline RD114 env gene, the gibbon ape leukemia virus (GLV) env gene, or the amphotropic 4070Aenv gene. This particular combination allows the production of high titer of non-replicative retrovirus pseudotyped and prevents the recombination of plasmids. The recombinant retroviruses produced from these cells are safer and easier to produce for clinical use in gene therapy.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018127781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016118775-A1
priorityDate 2006-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5910434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6210922-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006270042-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7015035-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5834256-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID247704
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127909126
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129329937

Total number of triples: 38.